Serveur d'exploration sur le peuplier

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The Alzheimer pandemic: is paracetamol to blame?

Identifieur interne : 002020 ( Main/Exploration ); précédent : 002019; suivant : 002021

The Alzheimer pandemic: is paracetamol to blame?

Auteurs : Günther Robert Norman Jones [Royaume-Uni]

Source :

RBID : pubmed:24350947

Descripteurs français

English descriptors

Abstract

HISTORICAL BACKGROUND

The clinical recognition of a form of dementia closely resembling Alzheimer's disease dates from around 1800. The role of analgesics derived from coal-tar in the spread of the pandemic is traced in terms of the introduction of phenacetin (PN) in 1887; its nephrotoxicity; the observation of lesions characteristic of the disease by Fischer and Alzheimer; the discovery of paracetamol (PA) as the major metabolite of PN; the linking of kidney injury and dementia with high PN usage; and the failure of PN replacement by PA to halt and reverse the exponential, inexorable rise in the incidence of Alzheimer-type dementia. Fischer observed his first case before Alzheimer; it is proposed to rename the syndrome Fischer-Alzheimer disease (F-AD). Disease development: PA-metabolising enzymes are localised in the synaptic areas of the frontal cortex and hippocampus, where F-AD lesions arise. The initiating chemical lesions in liver poisoning comprise covalent binding of a highly reactive product of PA metabolism to proteins; similar events are believed to occur in brain, where alterations in the antigenic profiles of cerebral proteins activate the microglia. β-Amyloid forms, and, like PA itself, induces nitric oxide synthase. Peroxynitrite modifies cerebral proteins by nitrating tyrosine residues, further challenging the microglia and exacerbating the amyloid cascade. Spontaneous reinnervation, N-acetyl cysteine administration and tyrosine supplementation may attenuate the early stages of F-AD development.

CONCLUSION

F-AD is primarily a man-made condition with PA as its principal risk factor.


DOI: 10.2174/1871528112666131219163405
PubMed: 24350947
PubMed Central: PMC3921468


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The Alzheimer pandemic: is paracetamol to blame?</title>
<author>
<name sortKey="Jones, Gunther Robert Norman" sort="Jones, Gunther Robert Norman" uniqKey="Jones G" first="Günther Robert Norman" last="Jones">Günther Robert Norman Jones</name>
<affiliation wicri:level="1">
<nlm:affiliation>30 Poplar Walk, London SE24 0BU, UK. darkshad@hotmail.co.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>30 Poplar Walk, London SE24 0BU</wicri:regionArea>
<wicri:noRegion>London SE24 0BU</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24350947</idno>
<idno type="pmid">24350947</idno>
<idno type="pmc">PMC3921468</idno>
<idno type="doi">10.2174/1871528112666131219163405</idno>
<idno type="wicri:Area/Main/Corpus">002368</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">002368</idno>
<idno type="wicri:Area/Main/Curation">002368</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">002368</idno>
<idno type="wicri:Area/Main/Exploration">002368</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The Alzheimer pandemic: is paracetamol to blame?</title>
<author>
<name sortKey="Jones, Gunther Robert Norman" sort="Jones, Gunther Robert Norman" uniqKey="Jones G" first="Günther Robert Norman" last="Jones">Günther Robert Norman Jones</name>
<affiliation wicri:level="1">
<nlm:affiliation>30 Poplar Walk, London SE24 0BU, UK. darkshad@hotmail.co.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>30 Poplar Walk, London SE24 0BU</wicri:regionArea>
<wicri:noRegion>London SE24 0BU</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Inflammation & allergy drug targets</title>
<idno type="eISSN">2212-4055</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acetaminophen (adverse effects)</term>
<term>Acetaminophen (metabolism)</term>
<term>Acetaminophen (therapeutic use)</term>
<term>Alzheimer Disease (drug therapy)</term>
<term>Alzheimer Disease (etiology)</term>
<term>Alzheimer Disease (history)</term>
<term>Amyloid beta-Protein Precursor (immunology)</term>
<term>Amyloid beta-Protein Precursor (metabolism)</term>
<term>Analgesics, Non-Narcotic (adverse effects)</term>
<term>Analgesics, Non-Narcotic (therapeutic use)</term>
<term>Animals (MeSH)</term>
<term>Autoantigens (immunology)</term>
<term>Autoantigens (metabolism)</term>
<term>Brain (drug effects)</term>
<term>History, 19th Century (MeSH)</term>
<term>History, 20th Century (MeSH)</term>
<term>History, 21st Century (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Metabolic Detoxication, Phase I (physiology)</term>
<term>Microglia (drug effects)</term>
<term>Microglia (physiology)</term>
<term>Pandemics (MeSH)</term>
<term>Peroxynitrous Acid (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide peroxynitreux (métabolisme)</term>
<term>Acétaminophène (effets indésirables)</term>
<term>Acétaminophène (métabolisme)</term>
<term>Acétaminophène (usage thérapeutique)</term>
<term>Analgésiques non narcotiques (effets indésirables)</term>
<term>Analgésiques non narcotiques (usage thérapeutique)</term>
<term>Animaux (MeSH)</term>
<term>Autoantigènes (immunologie)</term>
<term>Autoantigènes (métabolisme)</term>
<term>Détoxication de phase I (physiologie)</term>
<term>Encéphale (effets des médicaments et des substances chimiques)</term>
<term>Histoire du 19ème siècle (MeSH)</term>
<term>Histoire du 20ème siècle (MeSH)</term>
<term>Histoire du 21ème siècle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Maladie d'Alzheimer (histoire)</term>
<term>Maladie d'Alzheimer (traitement médicamenteux)</term>
<term>Maladie d'Alzheimer (étiologie)</term>
<term>Microglie (effets des médicaments et des substances chimiques)</term>
<term>Microglie (physiologie)</term>
<term>Pandémies (MeSH)</term>
<term>Précurseur de la protéine bêta-amyloïde (immunologie)</term>
<term>Précurseur de la protéine bêta-amyloïde (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Acetaminophen</term>
<term>Analgesics, Non-Narcotic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Amyloid beta-Protein Precursor</term>
<term>Autoantigens</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Acetaminophen</term>
<term>Amyloid beta-Protein Precursor</term>
<term>Autoantigens</term>
<term>Peroxynitrous Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Acetaminophen</term>
<term>Analgesics, Non-Narcotic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Brain</term>
<term>Microglia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Encéphale</term>
<term>Microglie</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Acétaminophène</term>
<term>Analgésiques non narcotiques</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="histoire" xml:lang="fr">
<term>Maladie d'Alzheimer</term>
</keywords>
<keywords scheme="MESH" qualifier="history" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Autoantigènes</term>
<term>Précurseur de la protéine bêta-amyloïde</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Acide peroxynitreux</term>
<term>Acétaminophène</term>
<term>Autoantigènes</term>
<term>Précurseur de la protéine bêta-amyloïde</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Détoxication de phase I</term>
<term>Microglie</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Metabolic Detoxication, Phase I</term>
<term>Microglia</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Maladie d'Alzheimer</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Acétaminophène</term>
<term>Analgésiques non narcotiques</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Maladie d'Alzheimer</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>History, 19th Century</term>
<term>History, 20th Century</term>
<term>History, 21st Century</term>
<term>Humans</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Histoire du 19ème siècle</term>
<term>Histoire du 20ème siècle</term>
<term>Histoire du 21ème siècle</term>
<term>Humains</term>
<term>Pandémies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>HISTORICAL BACKGROUND</b>
</p>
<p>The clinical recognition of a form of dementia closely resembling Alzheimer's disease dates from around 1800. The role of analgesics derived from coal-tar in the spread of the pandemic is traced in terms of the introduction of phenacetin (PN) in 1887; its nephrotoxicity; the observation of lesions characteristic of the disease by Fischer and Alzheimer; the discovery of paracetamol (PA) as the major metabolite of PN; the linking of kidney injury and dementia with high PN usage; and the failure of PN replacement by PA to halt and reverse the exponential, inexorable rise in the incidence of Alzheimer-type dementia. Fischer observed his first case before Alzheimer; it is proposed to rename the syndrome Fischer-Alzheimer disease (F-AD). Disease development: PA-metabolising enzymes are localised in the synaptic areas of the frontal cortex and hippocampus, where F-AD lesions arise. The initiating chemical lesions in liver poisoning comprise covalent binding of a highly reactive product of PA metabolism to proteins; similar events are believed to occur in brain, where alterations in the antigenic profiles of cerebral proteins activate the microglia. β-Amyloid forms, and, like PA itself, induces nitric oxide synthase. Peroxynitrite modifies cerebral proteins by nitrating tyrosine residues, further challenging the microglia and exacerbating the amyloid cascade. Spontaneous reinnervation, N-acetyl cysteine administration and tyrosine supplementation may attenuate the early stages of F-AD development.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>F-AD is primarily a man-made condition with PA as its principal risk factor.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24350947</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>11</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2212-4055</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Inflammation & allergy drug targets</Title>
<ISOAbbreviation>Inflamm Allergy Drug Targets</ISOAbbreviation>
</Journal>
<ArticleTitle>The Alzheimer pandemic: is paracetamol to blame?</ArticleTitle>
<Pagination>
<MedlinePgn>2-14</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="HISTORICAL BACKGROUND" NlmCategory="BACKGROUND">The clinical recognition of a form of dementia closely resembling Alzheimer's disease dates from around 1800. The role of analgesics derived from coal-tar in the spread of the pandemic is traced in terms of the introduction of phenacetin (PN) in 1887; its nephrotoxicity; the observation of lesions characteristic of the disease by Fischer and Alzheimer; the discovery of paracetamol (PA) as the major metabolite of PN; the linking of kidney injury and dementia with high PN usage; and the failure of PN replacement by PA to halt and reverse the exponential, inexorable rise in the incidence of Alzheimer-type dementia. Fischer observed his first case before Alzheimer; it is proposed to rename the syndrome Fischer-Alzheimer disease (F-AD). Disease development: PA-metabolising enzymes are localised in the synaptic areas of the frontal cortex and hippocampus, where F-AD lesions arise. The initiating chemical lesions in liver poisoning comprise covalent binding of a highly reactive product of PA metabolism to proteins; similar events are believed to occur in brain, where alterations in the antigenic profiles of cerebral proteins activate the microglia. β-Amyloid forms, and, like PA itself, induces nitric oxide synthase. Peroxynitrite modifies cerebral proteins by nitrating tyrosine residues, further challenging the microglia and exacerbating the amyloid cascade. Spontaneous reinnervation, N-acetyl cysteine administration and tyrosine supplementation may attenuate the early stages of F-AD development.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">F-AD is primarily a man-made condition with PA as its principal risk factor.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>Günther Robert Norman</ForeName>
<Initials>GR</Initials>
<AffiliationInfo>
<Affiliation>30 Poplar Walk, London SE24 0BU, UK. darkshad@hotmail.co.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016456">Historical Article</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United Arab Emirates</Country>
<MedlineTA>Inflamm Allergy Drug Targets</MedlineTA>
<NlmUniqueID>101266886</NlmUniqueID>
<ISSNLinking>1871-5281</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018712">Analgesics, Non-Narcotic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>14691-52-2</RegistryNumber>
<NameOfSubstance UI="D030421">Peroxynitrous Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>362O9ITL9D</RegistryNumber>
<NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018712" MajorTopicYN="N">Analgesics, Non-Narcotic</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050216" MajorTopicYN="N">Metabolic Detoxication, Phase I</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D030421" MajorTopicYN="N">Peroxynitrous Acid</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>10</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2013</Year>
<Month>11</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>11</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>10</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24350947</ArticleId>
<ArticleId IdType="pii">IADT-EPUB-58193</ArticleId>
<ArticleId IdType="pmc">PMC3921468</ArticleId>
<ArticleId IdType="doi">10.2174/1871528112666131219163405</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Vestn Ross Akad Med Nauk. 1999;(1):39-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10078062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Int Med Res. 1976;4(4 Suppl):34-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1026559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 1999 Jul;30(1):186-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10385655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Brain Res Rev. 1999 Aug;30(2):153-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10525172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aust N Z J Med. 1976 Oct;6(5):498-508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1071883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 2000 Apr;49(4):291-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10759684</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 2000 Apr;47(4):524-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10762167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Lett. 1999 Jul 2;269(1):52-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10821643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stat Med. 2000 Jun 15-30;19(11-12):1481-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10844713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2000;54(11 Suppl 5):S4-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10854354</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neural Transm Suppl. 2000;59:251-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10961436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2001 Jan;56(1):121-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11133268</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2001 Feb 14;285(6):739-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11176911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2001 Mar 24;357(9260):917-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11289348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ASAIO J. 2001 May-Jun;47(3):192-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11374754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Sci. 2001 Aug;62(2):212-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11452133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11875246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2002 May 1;22(9):3484-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11978825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2002 Oct 25;298(5594):789-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12399581</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 1976 Apr;33(4):217-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1259639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1992 Dec;32(6):818-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1281971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Pharmacol. 2003 Aug;59(4):313-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12827329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuropathol Exp Neurol. 1963 Oct;22:629-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14069842</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Neuropathol. 1992;84(3):225-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1414275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):343-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14660786</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Amino Acids. 2003 Dec;25(3-4):295-311</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14661092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Metab Rev. 2004 May;36(2):313-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15237857</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroepidemiology. 2004 Jul-Aug;23(4):159-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15279021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Psychogeriatr. 2004 Sep;16(3):259-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15559752</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Kidney Dis. 2005 Mar;45(3):448-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15754267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Environ Health Perspect. 2005 Sep;113(9):1230-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16140633</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Med. 1992 May;22(2):429-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1615110</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2005 Dec 17;366(9503):2112-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16360788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 2006 Nov 1;399(3):455-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16831125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7247-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1714596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharm Biomed Anal. 2007 May 9;44(1):150-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17287102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 2007 Apr;101(1):168-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17394464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Metab Dispos. 2007 Oct;35(10):1754-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17620348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1991 Oct;30(4):572-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1789684</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trop Geogr Med. 1991 Oct;43(4):345-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1812598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Exp Ther. 1949 Sep;97(1):58-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18140117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Chronic Kidney Dis. 2008 Apr;15(2):123-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18334236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacoepidemiol Drug Saf. 2008 Sep;17(9):912-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18398935</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2008 May 6;70(19):1672-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18458226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurobiol Aging. 2008 Aug;29(8):1127-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18534718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fortschr Neurol Psychiatr. 2008 Sep;76(9):517-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18712664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ment Sci. 1948 Apr;94(395):225-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18870578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain. 2009 Apr;132(Pt 4):1102-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18952676</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8362-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1924295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Investig Drugs. 2009 Aug;18(8):1147-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19589092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1990 Apr 28;335(8696):1037</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1970087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurol. 2009 Oct;5(10):542-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19724248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2010 Jun;41(2-3):242-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20195798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ageing Res Rev. 2010 Nov;9 Suppl 1:S6-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20813206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1990 Nov;40(11):1698-707</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2146525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2012 Mar 23;335(6075):1503-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22323736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Rep. 2012 Dec;32(6):521-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22697601</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Pharmacol. 1990 Mar;37(3):452-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2314392</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1990 Apr;27(4):428-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2353798</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Biochem Biophys. 1989 Jun;271(2):270-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2729995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 1989 Oct;24(3):173-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2808689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Chir Rev. 1839 Jan 1;30(59):37-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29918508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Geriatr Soc. 1977 Jul;25(7):289-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">301148</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Foreign Med Chir Rev. 1864 Apr;33(66):403-409</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30164077</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aust N Z J Med. 1988 May;18(3):251-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3056366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1987 Dec 1;6(12):3627-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3322812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med Bull. 1986 Jan;42(1):3-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3513890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs. 1986;32 Suppl 4:46-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3552585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1987 Mar;21(3):259-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3606033</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Lett. 1987 Aug 18;79(1-2):195-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3670729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1986 Jul;36(7):922-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3714054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1986 May;19(5):415-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3717905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Dial. 1979;3(4):277-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">400841</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1971 Jul 31;2(7718):242-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4104774</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1973 Jun 23;1(7817):1412-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4122984</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1971 Dec 4;2(7736):1260-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4143617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trans Am Soc Artif Intern Organs. 1972;18(0):257-61, 266-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4215188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Exp Ther. 1973 Oct;187(1):195-202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4746327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J. 1979 Nov 3;2(6198):1097-100</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">519312</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Experientia. 1969 Sep 15;25(9):956-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5371434</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med J Aust. 1969 Dec 6;2(23):1131-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5374050</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Rev Exp Pathol. 1976;15:1-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">56316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1966 Jan 1;209(5018):109-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5927229</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1984 Mar;81(5):1327-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6424115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Pharmacol. 1981 Jan;19(1):140-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6782444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Kidney Int. 1978 Jan;13(1):72-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">713271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Schweiz Med Wochenschr. 1982 Sep 4;112(36):1245-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7134951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 1981 Jul 13;29(2):107-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7289788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Pathol Microbiol Scand A. 1981 May;89(3):193-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7315316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 1995 Oct;152(10):1485-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7573588</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 1995 Mar;52(3):306-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7872886</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1993 Aug 12;364(6438):584</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8350919</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurobiol Aging. 1995 Jul-Aug;16(4):523-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8544901</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 1995 Sep 18;692(1-2):207-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8548305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 1996 Jul;149(1):21-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8686745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Neuroimmunol. 1995;5(4):411-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8746513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Brain Res Rev. 1995 Sep;21(2):195-218</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8866675</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1996 Oct 1;184(4):1425-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8879214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1997 Mar;48(3):626-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9065537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Appl Pharmacol. 1997 Mar;143(1):1-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9073586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 1997 Apr 15;17(8):2653-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9092586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1997 May 24;349(9064):1546-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9167474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 1997 Nov 7;774(1-2):193-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9452208</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 1998 Mar;27(3):748-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9500703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Neurol. 1998 Feb;149(2):329-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9500964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Geriatr Psychiatry. 1998 Spring;6(2 Suppl 1):S3-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9581216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Res Toxicol. 1998 Jun;11(6):604-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9625727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 1998 Oct 15;18(20):8126-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9763459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Appl Pharmacol. 1998 Sep;152(1):193-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9772215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 1998 Nov;4(11):1313-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9809557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Orv Hetil. 1998 Nov 22;139(47):2839-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9846064</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 1999 Jan;72(1):310-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9886083</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Jones, Gunther Robert Norman" sort="Jones, Gunther Robert Norman" uniqKey="Jones G" first="Günther Robert Norman" last="Jones">Günther Robert Norman Jones</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002020 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002020 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24350947
   |texte=   The Alzheimer pandemic: is paracetamol to blame?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24350947" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020